These facilities also lack diagnostic equipment, stroke specialists, timely interventions such as tissue-type plasminogen activator (t-PA) and low rehabilitation access rates (as low as 40%) for stroke survivors in some countries [2]. This evidence concerns the gene PLAT and Stroke.